A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci199277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Hannah M Kortbawi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Neuraminidase, Glycoproteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
BACKGROUND Infection by Trypanosoma cruzi , the agent of Chagas disease, is endemic to the Americas and can irreparably damage the cardiac and gastrointestinal systems during decades of parasite persistence. Diagnosis of chronic infection requires confirmation by multiple serological assays due to the imperfect performance of existing tests. Current serology tests were developed using small specimen sets predominantly from South America, and lower performance has been observed in patients who acquired infection in Central America and Mexico. METHODS To improve Chagas disease serology, we evaluated antibody responses against the entire T . cruzi proteome with phage display immunoprecipitation sequencing and further evaluated high-prevalence antigens by immunoassay. We utilized specimen sets representing Mexico, Central America, and South America and varying cardiac disease presentations, from 185 cases and 143 controls. RESULTS We identified over 1,300 antigenic T . cruzi peptides. A trans-sialidase antigen demonstrated high seroprevalence across all regions and has not previously been described as a diagnostic target to our knowledge. Orthogonal validation of this peptide demonstrated increased antibody reactivity for infections originating from Central America. CONCLUSION This study provides proteome-wide identification of seroreactive T . cruzi peptides across a range of endemic populations not previously represented in antigen discovery and identifies a trans-sialidase peptide antigen (TS23) with potential for translation into diagnostic serological assays. FUNDING Chan Zuckerberg Biohub, the Chan Zuckerberg Biohub Physician-Scientist Fellowship Program, the NIH National Heart Lung and Blood Institute award K38HL154203, and the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development award F30HD117526.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics.
- Medical Scientist Training Program.
- Department of Epidemiology and Biostatistics, and.
- Department of Laboratory Medicine, UCSF, San Francisco, California, USA.
- Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA.
- Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA.
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Chan Zuckerberg Biohub
Zitieren
APA
Kortbawi, H. M., Marczak, R. J., Rajan, J. V., Bulaong, N. L., Pak, J. E., Wu, W., Wang, G., Mitchell, A., Saxena, A., Maheshwari, A., Leone, R. A., Fleischmann, C. J., Kelly, E. A., Teal, E., Townsend, R. L., Stramer, S. L., Okamoto, E. E., Sherbuk, J. E., Clark, E. H., …, & Whitman, J. D. (2026). A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. Journal of Clinical Investigation. https://doi.org/10.1172/jci199277
Vancouver
Kortbawi HM, Marczak RJ, Rajan JV, Bulaong NL, Pak JE, Wu W, et al. A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. Journal of Clinical Investigation. 2026. doi:10.1172/jci199277
BibTeX
@article{Kortbawi2026,
author = {Kortbawi, Hannah M and Marczak, Ryan J and Rajan, Jayant V and Bulaong, Nash L and Pak, John E and Wu, Wesley and Wang, Grace and Mitchell, Anthea and Saxena, Aditi and Maheshwari, Aditi and Leone, Rachel Alfaro and Fleischmann, Charles J and Kelly, Emily A and Teal, Evan and Townsend, Rebecca L and Stramer, Susan L and Okamoto, Emi E and Sherbuk, Jacqueline E and Clark, Eva H and Gilman, Robert H and Colanzi, Rony Pedro and Gennatas, Efstathios D and Bern, Caryn and DeRisi, Joseph L and Whitman, Jeffrey D},
title = {A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci199277}
}
EUVIMED